KOAG

KOAG LLC, a Minneapolis-based medical device company engaged in designing innovative local vascular closure systems, announced today that its Vascette® HP device has received FDA approval. Vascette® is a unique local closure pad containing proprietary plant-derived hemostatic foam. The patent-pending technology of Vascette® supports rapid hemostasis (hemostasis) after cardiac catheterization without the need for direct compression of the arterial puncture site (arteriotomy).